Immediate Impact
9 from Science/Nature 72 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Works of Lisa D. Eli being referenced
Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer
2023
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lisa D. Eli | 303 | 118 | 144 | 292 | 26 | 526 | |
| Edward H. van der Horst | 293 | 69 | 130 | 380 | 20 | 629 | |
| Rachele Alzani | 249 | 66 | 90 | 246 | 25 | 575 | |
| Ioannis Roxanis | 300 | 83 | 171 | 178 | 18 | 526 | |
| Alexandr Kristian | 272 | 114 | 106 | 287 | 24 | 631 | |
| Uma Murthy | 242 | 54 | 205 | 342 | 16 | 597 | |
| Kristin Gurtner | 261 | 188 | 91 | 253 | 16 | 585 | |
| Daphne L. Farrington | 153 | 69 | 131 | 286 | 19 | 458 | |
| Monica Red Brewer | 382 | 219 | 197 | 351 | 12 | 615 | |
| Thomas Kryza | 257 | 112 | 67 | 251 | 32 | 626 | |
| Amy Jackson-Fisher | 337 | 71 | 116 | 351 | 20 | 637 |
All Works
Login with ORCID to disown or claim papers
Loading papers...